DCAT 2024

Bormioli Pharma leading the way with sustainable pharmaceutical packaging

By Liza Laws

- Last updated on GMT

© Bormioli Pharma
© Bormioli Pharma

Related tags Bormioli Pharma sustainability Manufacturing Contract manufacturing Supply chain facility

Bormioli Pharma creates pharmaceutical packaging for drug stability, safety, and sustainability, partnering with global health leaders and says it stands at the forefront of sustainability.

Andrea Lodetti, chief executive officer of Bormioli Pharma (pictured), tells OSP about this breakthrough within the pharmaceutical packaging industry. In an in-depth conversation, he shares profound insights into the company's notable journey toward sustainability and its ambitious trajectory in the pharmaceutical landscape. 

“Bormioli Pharma emerged as an independent entity six years ago, following a strategic carve-out from a larger conglomerate," Lodetti begins, reflecting on the company's origins.

“Initially, our focus was predominantly on manufacturing containers and closures for oral liquid applications within the pharmaceutical sector.”

Andrea Lodetti

However, Lodetti and his team swiftly recognized the pressing need for sustainability within the industry. It became abundantly clear that sustainability had to be central to our operations,” Lodetti stressed.

“Our objective was not just to meet industry standards but to surpass them by introducing cutting-edge, eco-friendly packaging solutions.”

Navigating through initial skepticism from industry stakeholders proved to be quite a challenge for Bormioli Pharma. “There was a degree of reluctance initially, as some were apprehensive about incorporating recycled materials into pharmaceutical packaging,” Lodetti adds.

“But undeterred by these challenges, we remained resolute in our commitment to innovation and sustainability, steadfast in our determination to demonstrate the viability and efficacy of recycled materials.”

Through relentless research and development efforts, Bormioli Pharma successfully established a robust supply chain for recycled materials.

“We undertook extensive efforts to cultivate a qualified supply chain for recycled materials, encompassing both mechanical and chemical recycling processes,” Lodetti explains.

“This breakthrough positioned us as pioneers in sustainable packaging solutions within the industry.”

Presently, Lodetti says Bormioli Pharma stands as a beacon of sustainability, earning widespread recognition for its eco-friendly initiatives.

“We have emerged as the preferred choice for pharmaceutical companies seeking sustainable packaging solutions,” Lodetti asserts.

“Our diverse portfolio of sustainable packaging solutions has garnered acclaim from customers and industry peers alike.”

Looking towards the future, Bormioli Pharma says it is committed to further amplifying its sustainability endeavors. “Our focus is firmly set on expanding our footprint in the US market,” Lodetti reveals. “By establishing manufacturing facilities in the US, we aim to minimize our environmental impact while bolstering our agility in responding to market dynamics.”

Lodetti says he is optimistic regarding the future trajectory of the pharmaceutical industry, underscoring the pivotal role of sustainability. “As the industry confronts pressing environmental challenges, sustainability will emerge as a linchpin for driving positive transformation," he says.

“Companies like Bormioli Pharma are spearheading the charge towards a greener, more sustainable future.”

With what he describes as an unwavering commitment to innovation, sustainability, and customer satisfaction, Bormioli Pharma, Lodetti says, is poised to shape the future of pharmaceutical packaging.

“We take immense pride in our role as trailblazers in sustainable packaging solutions," Lodetti concludes emphatically. "And we remain steadfast in our dedication to setting new benchmarks for excellence in sustainability, driving meaningful change within the industry.”

Related news

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Related suppliers

Follow us


View more